Inventor · disambiguated record
Kenneth L. Arrington
Also filed as: ARRINGTON KENNETH L
20 granted patents·8 pending applications·532 citations·filing 2000–2017
94Inventor score
Files withMERCK & CO INC11ARRINGTON KENNETH L6MERCK SHARP & DOHME4ALTMAN MICHAEL D3ANDRESEN BRIAN M1
Top patents by PatentIndex Score
28 records- 0198US6306874B1Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2000·Granted Oct 23, 2001·214 cites·36 claims
- 0297US6794393B1Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2000·Granted Sep 21, 2004·75 cites·3 claims
- 0396US10189831B2Non-nucleoside reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Jan 29, 2019·75 cites·17 claims
- 0495US6927293B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Aug 9, 2005·69 cites·2 claims
- 0593US8735417B2Aminopyrimidines as Syk inhibitorsALTMAN MICHAEL D·Filed 2010·Granted May 27, 2014·35 cites·13 claims
- 0692US8551984B2Aminopyrimidines as SYK inhibitorsALTMAN MICHAEL D·Filed 2010·Granted Oct 8, 2013·25 cites·40 claims
- 0790US8765784B2Positive allosteric modulators of MGLUR2ARRINGTON KENNETH L·Filed 2011·Granted Jul 1, 2014·20 cites·19 claims
- 0888US7501435B2Inhibitors of checkpoint kinasesMERCK & CO INC·Filed 2007·Granted Mar 10, 2009·8 cites·5 claims
- 0975US9499534B2Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Nov 22, 2016·1 cites·14 claims
- 1074US7101884B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Sep 5, 2006·6 cites·12 claims
- 1170US9718819B2Non-nucleoside reverse transcriptase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Aug 1, 2017·1 cites·19 claims
- 1266US8993779B2Positive allosteric modulators of MGLUR2DUDKIN VADIM Y·Filed 2011·Granted Mar 31, 2015·1 cites·9 claims
- 1366US2008274107A1Tyrosine kinase inhibitorsFRALEY MARK E·Filed 2008·Application pending·0 cites
- 1463US7169788B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Jan 30, 2007·2 cites·6 claims
- 1556US2014243290A1Aminopyrimidines as SYK InhibitorsALTMAN MICHAEL D·Filed 2014·Application pending·0 cites
- 1654US2005096344A1Tyrosine kinase inhibitorsFiled 2004·Application pending·0 cites
- 1752US9598405B2Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitorsMERCK SHARP & DOHME·Filed 2013·Granted Mar 21, 2017·0 cites·14 claims
- 1849US7625912B2Mitotic kinesin inhibitorsMERCK & CO INC·Filed 2004·Granted Dec 1, 2009·0 cites·5 claims
- 1944US7301028B2Mitotic kinesin inhibitorsMERCK & CO INC·Filed 2003·Granted Nov 27, 2007·0 cites·5 claims
- 2042US7348440B2Mitotic kinesin inhibitorsMERCK & CO INC·Filed 2003·Granted Mar 25, 2008·0 cites·13 claims
- 2142US2007149553A1Mitotic kinesin inhibitorsARRINGTON KENNETH L·Filed 2004·Application pending·0 cites
- 2242US2007060601A1Mitotic kinesin inhibitorsARRINGTON KENNETH L·Filed 2004·Application pending·0 cites
- 2341US7186723B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Mar 6, 2007·0 cites·9 claims
- 2441US7109204B2Tyrosine kinase inhibitorsMERCK & CO INC·Filed 2002·Granted Sep 19, 2006·0 cites·19 claims
- 2541US2008004259A1Inhibitors of Checkpoint KinasesARRINGTON KENNETH L·Filed 2006·Application pending·0 cites
- 2640US9822107B2Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitorsANDRESEN BRIAN M·Filed 2014·Granted Nov 21, 2017·0 cites·15 claims
- 2740US2009258852A1Inhibitors of Checkpoint KinasesARRINGTON KENNETH L·Filed 2006·Application pending·0 cites
- 2837US2009233896A1Inhibitors of checkpoint kinasesARRINGTON KENNETH L·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kenneth L. Arrington files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →